Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Non Operating Investment Income (2022 - 2024)

Historic Non Operating Investment Income for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q4 2024 value amounting to $3.0 million.

  • Indivior Pharmaceuticals' Non Operating Investment Income changed N/A to $3.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $9.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Indivior Pharmaceuticals' Non Operating Investment Income is $3.0 million.
  • In the past 5 years, Indivior Pharmaceuticals' Non Operating Investment Income ranged from a high of $3.0 million in Q4 2024 and a low of -$1.0 million during Q1 2023
  • For the 3-year period, Indivior Pharmaceuticals' Non Operating Investment Income averaged around $1.0 million, with its median value being $1.0 million (2022).